Clinical analysis of surgical treatment of portal hypertension

World Journal of Gastroenterology

Volumn 11, Issue 29, 2005, Pages 4552-4559

  Xu, Xin Bao ^a,b   Cai, Jing Xiu ^c   Leng, Xi Sheng ^a   Dong, Jia Hong ^c   Zhu, Ji Ye ^a   He, Zhen Ping ^c   Wang, Fu Shun ^a   Peng, Ji Run ^a   Han, Ben Li ^c   Du, Ru Yu ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Portal hypertension; Shunt; Surgical operation

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; CONTROLLED STUDY; DEVASCULARIZATION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INCIDENCE; LIVER CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE HEMORRHAGE; REVIEW; SURGICAL TECHNIQUE;

EID: 23844516436     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i29.4552     Document Type: Review

References (69)

1. Isaksson B, Hultberg B, Hansson L, Bengtsson F, Jeppsson B. Effect of mesocaval interposition shunting and repeated sclerotherapy on blood levels of gastrointestinal regulatory peptides, amino acids, and lysosomal enzymes-a prospective randomised trial. Liver 1999; 19: 3-11
2. Malesci A, Tacconi M, Valentini A, Basilico M, Lorenzano E, Salerno F. Octreotide long-term treatment in patients with portal hypertension: persistent inhibition of postprandial glucagon response without major changes in renal function. J Hepatol 1997; 26: 816-825
3. Gulberg V, Haag K, Rossle M, Gerbes AL. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 2002; 35: 630-634
4. Miyamoto Y, Oho K, Kumamoto M, Toyonaga A, Sata M. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol 2003; 18: 934-942
5. Asakura T, Ohkohchi N, Orii T, Koyamada N, Tsukamoto S, Sato M, Enomoto Y, Usuda M, Satomi S. Portal vein pressure is the key for successful liver transplantation of an extremely small graft in the pig model. Transpl Int 2003; 16: 376-382
6. Qiu FZ. Evaluation of the pericardial devascularization in portal hypertension. Zhonghua Waike Zazhi 1983; 21: 275-277
7. Huang YT, Wang WM, Wang JQ, Bai CN. Surgical treatment of portal hypertension:45 year experience. Zhonghua Waike Zazhi 2000; 38: 85-88
8. Chen FM, Wang JY, Huang TJ, Hsieh JS. The effect of portal hypertension on the glycoprotein biosynthesis of rat gastric mucosa. J Invest Surg 2002; 15: 311-317
9. Thuluvath PJ, Yoo HY. Portal Hypertensive gastropathy. Am J Gastroenterol 2002; 97: 2973-2978
10. Ohta M, Yamaguchi S, Gotoh N, Tomikawa M. Pathogenesis of portal hypertensive gastropathy: a clinical and experimental review. Surgery 2002; 131(1 Suppl): S165-170
11. Liu JK, Cai JX, Wang AC, Yang HW. Studies of functional and morphological changes of gastric mucosa after portoazygos disconnection in cirrhotic portal hypertension in rats. Disan Junyi Daxue Xuebao 1994; 16: 252-255
12. Chen L, Yang L, Yang Z, Dai Z. Magnetic resonance angiography in assessing changes of pre-and post-disconnective portal system in patients with portal hypertension. Zhonghua Waike Zazhi 2000; 38: 92-94
13. Guan H, Chen Y, Qian H. Expression of endothelin-1 and nitric oxide synthase mRNA in gastric mucosa of rats with cirrhosis and portal hypertensive gastropathy after disconnective operations. Zhonghua Yixue Zazhi 1998; 78: 702-703
14. Kojima K. Experimental and clinical studies on esophageal hemodynamics in the Sugiura procedure. Nippon Geka Gakkai Zasshi 1986; 87: 488-498
15. Xue H, Zhang H, Zhang Y, Jiang Q. Portal anticoagulation in preventing thrombosis after portaazygous devascularization for portal hypertension. Zhonghua Waike Zazhi 2000; 38: 855-857
16. Gao D, He Z, Wu J, Ma Q, Song H, Mei L, Wu Y. Long-term results of combined splenorenal shunt and portaazygous devascularization in patients with portal hypertension. Zhonghua Waike Zazhi 1998; 36: 327-329
17. Rosemurgy AS, Zervos EE, Bloomston M, Durkin AJ, Clark WC, Goff S. Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve. Ann Surg 2003; 237: 820-827
18. Leng X, Zhu J, Du R. Portacaval shunt with H-grafts of small diameter in treating cirrhotic patients with portal hypertension. Zhonghua Waike Zazhi 1998; 36: 330-332
19. Cai J, Dong J, Gu H. Inferior mesocaval shunt. Zhonghua Waike Zazhi 1996; 34: 151-153
20. D'Cruz K, Natarajan A. Emergency inferior mesenteric vein to left renal vein shunt in variceal bleeding: an alternative technique. Trop Gastroenterol 2001; 22: 230-231
21. Rahmani O, Wolpert LM, Drezner AD. Distal inferior mesenteric veins to renal vein shunt for treatment of bleeding anorectal varices: case report and review of literature. J Vasc Surg 2002; 36: 1264-1266
22. Triger DR. Portal hypertensive gastropathy. Baillieres Clin Gastroenterol 1992; 6: 481-495
23. Ekelund M, Hakanson R, Holmin T, Oscarson J, Rehfeld JF, Sundler F, Westrin P. Effects of portacaval shunt on the rat stomach. Acta Physiol Scand 1985; 124: 437-447
24. Liu Jikui, Cai JX, Duan HC, Yang HW. Effects of portacaval shunt on gastric mucosa in cirrhotic rats with portal hypertension. Zhonghua Shiyan Waike Zazhi 1997; 14: 18-20
25. Zhang Z, Feng H, Leng X, Ma F, Wang B, Du R. The levels of rinin activity, angiotensin coverting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt. Zhonghua Waike Zazhi 1999; 37: 366-368
26. Primignani M, Dell'Era A, Fazzini L, Zatelli S, de Franchis R. Portal hypertensive gastropathy in patients with cirrhosis of the liver. Recenti Prog Med 2001; 92: 735-740
27. Gusberg RJ. Distal splenorenal shunt-premise, perspective, practice. Dig Dis 1992; 10(Suppl 1): 84-93
28. Mercado MA, Orozco H, Ramirez-Cisneros FJ, Hinojosa CA, Plata JJ, Alvarez-Tostado J. Diminished morbidity and mortality in portal hypertension surgery: relocation in the therapeutic armamentarium. J Gastrointest Surg 2001; 5: 499-502
29. Zhu J, Liu F, Leng X. Perioperative plasma amino acid spectrum analysis in portal hypertensive cirrhotic patients undergoing portacaval H-graft shunt. Zhonghua Waike Zazhi 1997; 35: 299-301
30. Feng H, Zhang Z, Leng X, Li S, Zhu J, Du R. Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts. Zhonghua Waike Zazhi 1999; 37: 222-224
31. Weng Y, Wang Y, Xue J, Zhang Z, Zhou Y, Chen D, Li C. The influence of side-to-side portacaval shunt plus enhancement of perfusion of hepatic artery on cirrhotic liver: an experimental study. Zhonghua Waike Zazhi 1998; 36: 487-490
32. Warren WD, Zeppa R, Fomon JJ. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967; 166: 437-455
33. Inokuchi K. A selective portacaval shunt. Lancet 1968; 2: 51-52
34. Inokuchi K, Kobayashi Y. Selective shunt method for portal hypertension-our method of the left gastric venous-caval shunt. Shujutsu 1969; 23: 138-150
35. Holmin T, Schroder R, Berchtold R. A technique for distal splenocaval shunt in the rat. World J Surg 1977; 1: 661-665
36. Bhalerao RA, Pinto AC, Bapat RD, Shetty SV, Bhide PD, Waingankar VS, Kirtane JM, Mehendale VG, Shetty SD. Selective transplenic decompression of oesophageal varices by distal splenorenal and splenocaval shunt. Gut 1978; 19: 831-837
37. Cai J, Dong J, Gu H, Bie P, Wang S, Sun W, Liu J, Zhou Y, Peng Z, Wang A. Distal splenocaval shunt in 66 patients with portal hypertension. Zhonghua Waike Zazhi 1998; 36: 336-338
38. Spina GP, Santambrogio R, Opocher E, Cosentino F, Zambelli A, Passoni GR, Cucchiaro G, Macri M, Morandi E, Bruno S. Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. First stage of a randomized, controlled trial. Ann Surg 1990; 211: 178-186
39. Liu JK, Cai JX, Duan HC, Yang HW. Effects of distal splenocaval shunt on gastric mucosa in cirrhotic portal hypertension in rats. Zhonghua Shiyan Waike Zazhi 1997; 14: 104-105
40. Xu XB, Cai JX, Dong JH, Han BL. Effects of different operations on mitochondrial respiratory function of cirrhotic liver in rats. Disan Junyi Daxue Xuebao 1996; 18: 48-51
41. Wu G, Cai JX, Dong JH, Duan HC. Effects of different types of operation on hepatic reserve function in rats with cirrhotic portal hypertension. Disan Junyi Daxue Xuebao 1998; 20: 37-39
42. Xue XB, Cai JX, Dong JH, Han BL, Lin K, Leng XS. Effects of the different procedures on the Portasystemic shunting and the hepatic function in the rats. J Dig Surg 2004; 3: 46-49
43. Xu XB, Cai JX, Dong JH, He ZP, Han BL, Leng XS. Effects of different operations on cirrhotic portal hypertensive liver in rats. Shijie Huaren Xiaohua Zazhi 2004; 12: 689-693
44. Xu XB, Cai JX, Dong JH, He ZP, Han BL, Leng XS. Effects of portaazygous disconnection, portacaval shunt and selective shunts on experimental rat liver cirrhosis. Zhonghua Ganzangbing Zazhi 2005; 13: 113-116
45. Li MX, Wang AC, Cai JX. Effects of distal splenocaval shunt on hemorheology. Disan Junyi Daxue Xuebao 1993; 15: 532-535
46. Millikan WJ Jr, Warren WD, Henderson JM, Smith RB 3rd, Salam AA, Galambos JT, Kutner MH, Keen JH. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg 1985; 201: 712-722
47. Henderson JM, Kutner MH, Millikan WJ Jr, Galambos JT, Riepe SP, Brooks WS, Bryan FC, Warren WD. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med 1990; 112: 262-269
48. Raia S, da Silva LC, Gayotto LC, Forster SC, Fukushima J, Strauss E. Portal hypertension in schistosomiasis: a long-term follow-up of a randomized trial comparing three types of surgery. Hepatology 1994; 20: 398-403
49. Rikkers LF, Rudman D, Galambos JT, Fulenwider JT, Millikan WJ, Kutner M, Smith RB 3rd, Salam AA, Sones PJ Jr, Warren WD. A randomized, controlled trial of the distal splenorenal shunt. Ann Surg 1978; 188: 271-282
50. Nordlinger BM, Nordilinger DF, Fulenwider JT, Millikan WJ, Sones PJ, Kutner M, Steele R, Bain R, Warren WD. Angiography in portal hypertension: clinical significance in surgery. Am J Surg 1980; 139: 132-141
51. Huang YQ, Zhong YF. Evaluation of the remote results of various procedures in the treatment of portal hypertension. Zhonghua Waike Zazhi 1986; 24: 722-724
52. Cao Y, Cui L, Meng F, Wang M, Wang R, Han W. Treatment of portal hypertension by using pericardial vascular disconnection and mesocaval side-to-side shunting. Zhonghua Waike Zazhi 1998; 36: 339-341
53. Xu CE, Zhang SG, Yu ZH, Li GX, Cao LL, Ruan CL, Li ZT. Combined devascularization and proximal splenorenal shunt: is this a better option than either procedure alone? Hepatobiliary Pancreat Surg 2004; 11: 129-134
54. Li Z, Zhao L, Yu Z, Zhong Z. Effect of combined operation including splenorenal shunt as the main technique for portal hypertension in children. Zhonghua Waike Zazhi 2000; 38: 601-603
55. Huang CT, Wang WM, Dai ZB. Survey of surgical treatment to portal hypertension in China. Zhonghua Waike Zazhi 1998; 36: 324-326
56. Yang Z, Qiu F. Pericardial devascularization with splenectomy for the treatment of portal hypertension. Zhonghua Waike Zazhi 2000; 38: 645-648
57. Ùeo W, Sung JY, Chung SCS. A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma. Dig Dis Sci 1995; 40: 2516-2521
58. Minagawa N. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001; 233: 379-384
59. Pinto HC, Abrantes A, Esteves AV. Long term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding. Am J Gastroenterol 1989; 84: 1239-1243
60. Yang W, Wang GJ, Ding SQ, Liu QG, Pan CE. Surgical management of liver carcinoma accompanied by portal hypertension. Zhonghua Putong Waike Zazhi 2002; 17: 200-201
61. Zhang ZL, Hu JK, Jin ZT. Surgical treatment for hepatocellular carcinoma and concomitant portal hypertension. Zhongguo Shiyong Waike Zazhi 2002; 22: 85-87
62. Li H, Hu YL, Wang Y, Zhang DS, Jiang FX. Simultaneous operative treatment of patients with primary liver cancer associated with portal hypertension. Hepatobiliary Pancreat Dis Int 2002; 1: 92-93
63. Chen WC, Hou MC, Lin HC. Feasibility and potential benefit of maintenance endoscopic variceal ligation patients with unrescectable hepatocellular carcinoma and acute esophageal variceal hemorrhage: a controlled trial. Gastrointest Endosc 2001; 54: 18-23
64. Letier MH, Krige JE, Lemmer ER, Terblanche J. Injection sclerotherapy for variceal bleeding in patients with irresectable hepatocellular carcinoma. Hepatogastroenterology 2000; 47: 1680-1684
65. Zhang ZM, Leng XS, Feng HQ, Zhang WF, Pan T, Du RY. The changes of plasma renin activity in cirrhotic patients with ascites undergoing portacavalshunt. Zhonghua Putong Waike Zazhi 2001; 16: 395-396
66. Sola-Vera J, Minana J, Ricart E, Planella M, Gonzalez B, Torras X, Rodriguez J, Such J, Pascual S, Soriano G, Perez-Mateo M, Guarner C. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003; 37: 1147-1153
67. Jalan R, Hayes PC. Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut 2000; 46: 527-533
68. Orozco H, Mercado MA, Martinez R, Tielve M, Chan C, Vasquez M, Zenteno-Guichard G, Pantoja JP. Is splenectomy necessary in devascularization procedures for treatment of bleeding portal hypertension? Arch Surg 1998; 133: 36-38
69. Xu R, Ling Y, Qiu W. The different influences of splenectomy plus ligation of pericardial vein and shunt on portal hypertensive gastropathy. Zhonghua Waike Zazhi 1997; 35: 515-517